Is Metoprolol Succinate Tablet, Extended Release in shortage?
Metoprolol Succinate Tablet, Extended Release is listed by FDA as being discontinued by at least one maker (updated Aug 31, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-8800
- Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-8800
- Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-8800
- Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-8800
- Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-8800
- Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-8800
- Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96)
A business decision was made to discontinue manufacture of the drug.
Maker contact: 800-545-8800
FDA recalls of Metoprolol Succinate
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Metoprolol Succinate Tablet, Extended Release:
- Ascend Laboratories, LLC recalls Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem
- Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000
- Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany,
- Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles
- Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles
- Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b)
- Amerisource Health Services LLC recalls Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, packaged in (a) 100-count bottle, NDC 68001-501-00; (b)
- Ascend Laboratories, LLC recalls Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 500 Tablets per bottle, Manufactured by: Alkem
- Ascend Laboratories, LLC recalls Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem
- Ascend Laboratories, LLC recalls Metoprolol Succinate Extended-Release Tablets, USP 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem
- CARDINAL HEALTHCARE recalls Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North
- Ascend Laboratories, LLC recalls Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Tablets per bottle, Manufactured by: Alkem
Metoprolol Succinate Tablet, Extended Release shortage questions
Is Metoprolol Succinate Tablet, Extended Release in shortage?
Metoprolol Succinate Tablet, Extended Release is listed by FDA as being discontinued by at least one maker (updated Aug 31, 2026).
What should I do if I can’t get Metoprolol Succinate Tablet, Extended Release?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.